Literature DB >> 15520761

Low vitamin D status in children with sickle cell disease.

Anne M Buison1, Deborah A Kawchak, Joan Schall, Kwaku Ohene-Frempong, Virginia A Stallings, Babette S Zemel.   

Abstract

OBJECTIVES: To examine vitamin D status in children with sickle cell disease (SCD)-SS and its relation to season and dietary intake. STUDY
DESIGN: Growth, dietary intake, 25-hydroxyvitamin D (25-OHD), and parathyroid hormone levels were measured. Children with low and normal vitamin D status were compared. Low vitamin D status was defined as a serum concentration of 25-OHD <27.5 nmol/L. Serum 25-OHD and parathyroid hormone levels were compared among children with SCD-SS and healthy children.
RESULTS: Children with SCD-SS (n=65), 5 to 18 years of age, were evaluated. Mean (+/-SD) serum 25-OHD concentration was 25.5 +/- 12.8 nmol/L; 65% of subjects had low vitamin D status. Low vitamin D prevalence was highest during spring (100%). Children with SCD-SS were at higher risk for low vitamin D status than healthy children. Vitamin D intake was lower in subjects with SCD-SS and low vitamin D than those with normal serum vitamin D status (P <.05).
CONCLUSIONS: Low serum vitamin D status was highly prevalent in black children with SCD-SS. Vitamin D status was associated with season and dietary intake.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15520761     DOI: 10.1016/j.jpeds.2004.06.055

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  31 in total

1.  Bone density assessment in patients with mucopolysaccharidosis: A preliminary report from patients with MPS II and VI.

Authors:  Ellen B Fung; Jo Ann Johnson; Jacqueline Madden; Tiffany Kim; Paul Harmatz
Journal:  J Pediatr Rehabil Med       Date:  2010

2.  Vitamin D deficiency and comorbidities in children with sickle cell anemia.

Authors:  Tara Christine Jackson; Melissa Jo Krauss; Michael Rutledge Debaun; Robert Charles Strunk; Ana Maria Arbeláez
Journal:  Pediatr Hematol Oncol       Date:  2012-04       Impact factor: 1.969

3.  Markers of bone turnover are associated with growth and development in young subjects with sickle cell anemia.

Authors:  Ellen B Fung; Deborah A Kawchak; Babette S Zemel; Alisha J Rovner; Kwaku Ohene-Frempong; Virginia A Stallings
Journal:  Pediatr Blood Cancer       Date:  2008-03       Impact factor: 3.167

4.  Vitamin D concentrations among healthy children in Calgary, Alberta.

Authors:  Cristina A Stoian; Martha Lyon; Robin G Cox; David K Stephure; Jean K Mah
Journal:  Paediatr Child Health       Date:  2011-02       Impact factor: 2.253

Review 5.  Vitamin D supplementation for sickle cell disease.

Authors:  Htoo Htoo Kyaw Soe; Adinegara Bl Abas; Nan Nitra Than; Han Ni; Jaspal Singh; Abdul Razzak Bin Mohd Said; Ifeyinwa Osunkwo
Journal:  Cochrane Database Syst Rev       Date:  2017-01-20

Review 6.  A review on vitamin d deficiency treatment in pediatric patients.

Authors:  Ji Yeon Lee; Tsz-Yin So; Jennifer Thackray
Journal:  J Pediatr Pharmacol Ther       Date:  2013-10

7.  Height-corrected low bone density associates with severe outcomes in sickle cell disease: SCCRIP cohort study results.

Authors:  Oyebimpe O Adesina; James G Gurney; Guolian Kang; Martha Villavicencio; Jason R Hodges; Wassim Chemaitilly; Sue C Kaste; Babette S Zemel; Jane S Hankins
Journal:  Blood Adv       Date:  2019-05-14

8.  Response to Long-term Vitamin D Therapy for Bone Disease in Children With Sickle Cell Disease.

Authors:  Kristen M Williams; Margaret T Lee; Maureen Licursi; Gary M Brittenham; Ilene Fennoy
Journal:  J Pediatr Hematol Oncol       Date:  2018-08       Impact factor: 1.289

9.  TNF-α, IFN-γ, IL-10, and IL-4 levels were elevated in a murine model of human sickle cell anemia maintained on a high protein/calorie diet.

Authors:  Hyacinth I Hyacinth; Patrice L Capers; David R Archer; Jacqueline M Hibbert
Journal:  Exp Biol Med (Maywood)       Date:  2013-11-26

10.  Fracture prevalence and relationship to endocrinopathy in iron overloaded patients with sickle cell disease and thalassemia.

Authors:  Ellen B Fung; Paul R Harmatz; Meredith Milet; Thomas D Coates; Alexis A Thompson; Mark Ranalli; Robert Mignaca; Charles Scher; Patricia Giardina; Shanda Robertson; Lynne Neumayr; Elliott P Vichinsky
Journal:  Bone       Date:  2008-03-15       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.